Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation

By Loumaye Ernest  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 314-322

Oxford University Press

Access to resources Recommend Favorite

Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study

By Platteau Peter   Andersen Anders Nyboe   Balen Adam   Devroey Paul   Sørensen Per   Helmgaard Lisbeth   for the Menopur Ovulation Induction (MOI) Study Group  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1798-1804

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa

By Matorras R.   Recio V.   Corcóstegui B.  

Human Reproduction, Vol. 15, Iss. 6, 2000-06 ,pp. : 1231-1234

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)

By Lenton E.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1021-1027

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

By Daya S.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2563-2569

Oxford University Press

Access to resources Recommend Favorite